CRLX301: Phase I data

Data from 20 patients with advanced solid tumors in the Phase I portion of an open-label, international Phase

Read the full 187 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE